禾元生物科创板IPO申请即将上会，适用第五套标准

Group 1 - The core point of the article is that Wuhan Heyuan Biotechnology Co., Ltd. is set to have its IPO application reviewed by the Shanghai Stock Exchange on July 1, under the fifth set of standards for the Sci-Tech Innovation Board [1] Group 2 - The listing review committee of the Shanghai Stock Exchange has announced the upcoming meeting to assess Heyuan Biotechnology's IPO application [1] - Heyuan Biotechnology plans to adopt the fifth set of standards for its listing on the Sci-Tech Innovation Board [1]